34
14
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2035 |
WHI-P258
|
EGFR; JAK; JNK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; MAPK; Stem Cells; Tyrosine Kinase/Adaptors |
WHI-P258 是喹唑啉化合物,结合到JAK3的活性位点(Ki:72 µM)。甚至当WHI-P258到达 100 μM 时也不会抑制 JAK3 ,且对凝血酶诱导的血小板聚集无影响。 | |||
T7685 |
USP25/28 inhibitor AZ1
AZ1 |
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
USP25/28 inhibitor AZ1 (AZ1) 是一种口服有效,选择性,非竞争性的双重泛素特异性蛋白酶 USP25/28抑制,IC50分别为 0.7 μM 和0.6 μM。它有抗炎和抗肿瘤作用。 | |||
T14984 |
CLP257
|
Potassium Channel | Membrane transporter/Ion channel |
CLP257 是有效的 K+-Cl- 协同转运蛋白 KCC2 选择性激活剂 (EC50: 616 nM)。它可减轻神经性疼痛大鼠的超敏反应,并在翻译后调节质膜 KCC2 蛋白周转。它在 KCC2 活性降低的神经元中恢复受损的 Cl- 转运。 | |||
T2304 |
SP2509
HCI-2509 |
Apoptosis; Histone Demethylase | Apoptosis; Chromatin/Epigenetic |
SP2509 是一种选择性 LSD1拮抗剂,IC50值为 13 nM。 | |||
T14334 |
ASP2535
|
GlyT | Neuroscience |
ASP2535 is a potent, selective, orally bioavailable, brain permeable and centrally-active glycine transporter-1 (GlyT1) inhibitor.ASP2535 can improve cognitive impairment in animal models of schizophrenia and Alzheimer's disease[1]. | |||
T69855 |
USP25/28-IN-AZ2
|
||
USP25/28-IN-AZ2 is a novel potent, selective, dual usp25/28 inhibitor | |||
T6358 |
1-Azakenpaullone
1-氮杂坎帕罗酮,azakenpaullone |
GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
1-Azakenpaullone (azakenpaullone) 是一种 ATP 竞争性的、具有高度选择性的糖原合成酶激酶3 β (GSK-3β)的抑制剂,其 IC50=18 nM。 | |||
T6787 |
BIO-acetoxime
BIA,GSK-3 Inhibitor X |
Apoptosis; GSK-3; HSV | Apoptosis; Microbiology/Virology; PI3K/Akt/mTOR signaling; Stem Cells |
BIO-acetoxime (GSK-3 Inhibitor X) 是一种 GSK3α/β 抑制剂,IC50值均为 10 nM,具有抗惊厥和抗感染作用。 | |||
T61439 |
DSS30
|
Beta Amyloid; BACE; CDK | Cell Cycle/Checkpoint; Neuroscience |
DSS30 是一种 P25/CDK5抑制剂。DSS30通过抑制淀粉样前体蛋白裂解酶1 (BACEl) 磷酸化,减少 β-淀粉样蛋白 (Aβ) 的分泌发挥作用。DSS30 可用于预防和治疗阿尔茨海默病等神经退行性疾病。 | |||
T37207L |
Cdk5 Substrate acetate
|
CDK | Cell Cycle/Checkpoint |
Cdk5 Substrate acetate 是一种丝氨酸/苏氨酸激酶,主要在神经元组织中具有活性。与 p25 或 p35 一起,Cdk5 磷酸化一系列蛋白质,包括组蛋白 H1 和 tau。 它是一种合成肽 (PKTPKKAKKL),对应于组蛋白 H1 的序列。它被 Cdk5 磷酸化,Km 值为 5 µM。 | |||
T21715 |
BRD6688
|
HDAC | Chromatin/Epigenetic; DNA Damage/DNA Repair |
BRD6688 为 HDAC2 的选择性抑制剂。本品可使原代小鼠神经元细胞中的 H4K12 和 H3K9 组蛋白的乙酰化作用增强。在 CK-p25 小鼠模型中,它可透过血脑屏障,并改善由p25 引起的神经退行性病变相关的记忆缺陷。 | |||
T5200 |
Indirubin-3'-monoxime
靛玉红-3' -单肟,Indirubin-3'-oxime |
GSK-3; Lipoxygenase; CDK | Cell Cycle/Checkpoint; Metabolism; PI3K/Akt/mTOR signaling; Stem Cells |
Indirubin-3'-monoxime (Indirubin-3'-oxime) 是一种有效的 GSK3β 抑制剂,IC50值为 22 nM。它对 CDK5/p25、CDK1/cyclin B 和CDk2/cyclin E 也有作用,IC50值分别为 100、180 和 250 nM。 | |||
T14943 |
CGP60474
|
VEGFR; CDK; PKC | Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
CGP60474 是一种高效的抗内毒素药物,抑制细胞周期蛋白依赖激酶(CDK) ,抑制 CDK1/B、CDK2/E、CDK2/a、CDK4/D、CDK5/p25、CDK7/H 和 CDK9/T 的IC50分别为 26、3、4、216、10、200 和 13 nM。它是选择性和 ATP 竞争性PKC 抑制剂。 | |||
T2247 |
KenPaullone
9-Bromopaullone,NSC-664704,9-溴-7,12-二氢吲哚并[3,2-D][1]苯并氮杂卓-6(5H)-酮 |
GSK-3; CDK | Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells |
KenPaullone (9-Bromopaullone) 是一种CDK1/cyclin B 和GSK-3β抑制剂,IC50值分别为 0.4 μM 和 23 nM。它也抑制 CDK2/cyclin A、CDK2/cyclin E 和 CDK5/p25 的活性,IC50值分别为 0.68 μM、7.5 μM 和 0.85 μM。。它通过增强 TGFβ-Smad3 信号通路增加和延长 foxp3 基因的转录来促进 iTreg 细胞分化。 | |||
T10172 |
5-Iodo-indirubin-3'-monoxime
|
GSK-3; CDK | Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells |
5-Iodo-indirubin-3'-monoxime 是一种 GSK-3β、CDK5/P25和CDK1/cyclin B 抑制剂,IC50值分别为 9、20 和 25 nM,与 ATP 竞争性地结合酶的催化位点。 | |||
T25650 |
LDN-193665
LDN 193665,LDN193665 |
||
LDN-193665 is a potent inhibitor of tau kinase. It acts by targeting CDK5/p25 and GSK3β. | |||
T24734 |
RP-106
RP 106 |
||
RP-106 is an ATP-competitive inhibitor of CDK5/p25, CDK1/cyclin B, and GSK-3. | |||
T63184 | CDK5-IN-2 | ||
CDK5-IN-2 (compound 15) 是一种高选择性的 CDK5 抑制剂,能够作用于 CDK5/p25 (IC50: 0.2 nM) 和 CDK2/CycA (IC50: 23 nM)。 | |||
T61890 |
(E/Z)-BIO-acetoxime
|
||
(E/Z)-BIO-acetoxime 是有效的,选择性的GSK-3α/β 抑制剂。对于GSK-3α/β,CDK5/p25,CDK2/cyclin A 和CDK1/cyclin B 的IC50分别为10nM,2.4μM, 4.3μM, 63μM。 | |||
T21377 | Aloisine A | ||
Aloisine A is a potent and selective CDK/GSK-3 inhibitor. IC50 data of Aloisine A: Cdk1/cyclin B (IC50: 150nM), Cdk2/cyclin A (IC50: 120nM), Cdk2/cyclin E (IC50: 400nM), Cdk5/p25 (IC50: 200nM), Cdk5/p35 (IC50: 160nM), GSK-3α (IC50: 500nM), GSK-3β (IC50: 6 | |||
T61362 |
CDK5-IN-3
|
||
CDK5-IN-3 (compound 11) is a highly potent and selective inhibitor of CDK5, demonstrating significant inhibition with IC50 values of 0.6 nM and 18 nM for CDK5/p25 and CDK2/CycA, respectively. This compound holds promise for further investigation in the context of autosomal dominant polycystic kidney disease (ADPKD) research [1]. | |||
T37207 |
Cdk5 Substrate
Cdk5 Substrate |
||
Cyclin-dependent kinase 5 (Cdk5) is a serine/threonine kinase that is predominantly active in neuronal tissues. With p25 or p35, Cdk5 phosphorylates a range of proteins, including histone H1 and tau. Cdk5 substrate is a synthetic peptide (PKTPKKAKKL) corresponding to a sequence of histone H1. It is phosphorylated by Cdk5 with a Km value of 5 μM. | |||
T63851 | CDK9/10/GSK3β-IN-1 | ||
CDK9/10/GSK3β-IN-1 是一种激酶抑制剂 (Flavopiridol 类似物),能有效抑制 HsGSK3β、HsCDK9/CyclinT、HsCDK5/p25 和 HsCDK2/CyclinA,其 IC50 值分别为 59 nM、64 nM、1.093 μM 和 1.725 μM。CDK9/10/GSK3β-IN-1 表现出相当或高于 Flavopiridol 的抗癌细胞活性,在体外对多达七种癌细胞系表现出高抗增殖活性。 | |||
T21966 |
MeBIO
|
GSK-3; Aryl Hydrocarbon Receptor; CDK | Cell Cycle/Checkpoint; Immunology/Inflammation; PI3K/Akt/mTOR signaling; Stem Cells |
MeBIO 是一种芳烃受体激动剂,对 GSK-3 和 CDK1/CyclinB 的 IC50 分别为 44 和 55 μM。 MeBIO 不影响 GSK-3β。 | |||
T2113 |
PHA-793887
PHA 793887,PHA793887 |
Apoptosis; CDK | Apoptosis; Cell Cycle/Checkpoint |
PHA-793887 是一种ATP 竞争性的CDK 抑制剂,可抑制 Cdk2、Cdk1、Cdk4 和 Cdk9 的活性,IC50值分别为 8 nM、60 nM、62 nM 和 138 nM,同时可抑制糖原合酶激酶 3β,IC50值为 79 nM。 | |||
T12617L |
(R)-CR8
(R)-CR8,(R)-Isomer,(2R)-2-[[9-异丙基-6-[[[4-(2-吡啶基)苯基]甲基]氨基]-9H-嘌呤-2-基]氨基]-1-丁醇,CR8 |
Apoptosis; CDK | Apoptosis; Cell Cycle/Checkpoint |
(R)-CR8 ((R)-Isomer) 是 Roscovitine 类似物,是CDK1/2/5/7/9抑制剂。它作为一种分子胶降解剂来消耗细胞周期蛋白 K。它诱导细胞凋亡并具有神经保护作用。 | |||
T8484 |
JSH-150
|
CDK | Cell Cycle/Checkpoint |
JSH-150 是一种高选择性的 CDK9抑制剂, IC50为 1 nM。 | |||
T12617 |
(R)-CR8 trihydrochloride
CR8, (R)-Isomer trihydrochloride |
Apoptosis; CDK | Apoptosis; Cell Cycle/Checkpoint |
(R)-CR8 trihydrochloride (CR8, (R)-Isomer trihydrochloride) 是一种 CDK1/2/5/7/9 抑制剂,可作为分子胶降解剂,具有神经保护活性,可诱导细胞凋亡。 | |||
T16359 |
NU6140
|
CDK; Aurora Kinase | Cell Cycle/Checkpoint; Chromatin/Epigenetic |
NU6140 是选择性CDK2-cyclin A 抑制剂,IC50为0.41 μM。它显示出比其他 CDK 高 10 到 36 倍的选择性。它还抑制Aurora A 和Aurora B 的活性,IC50值分别为 67 和 35 nM。它还增强细胞凋亡作用并具有抗癌活性。 | |||
T5533 |
MC180295
(rel)-MC180295 |
CDK | Cell Cycle/Checkpoint |
MC180295 ((rel)-MC180295) 是一种有效、选择性的CDK9抑制剂,IC50值为 5 nM。它对其选择性至少是对其他 CDK 激酶 22 倍,具有的抗肿瘤活性。 | |||
T11345L |
Lerociclib dihydrochloride
G1T38 dihydrochloride |
CDK | Cell Cycle/Checkpoint |
Lerociclib dihydrochloride (G1T38 dihydrochloride) 是一种有效的选择性CDK4/CDK6抑制剂,抑制CDK6/CyclinD3和CDK4/CyclinD1,IC50值分别为 2 nM 和 1 nM。 | |||
TQ0068 |
NVP-LCQ195
AT9311,LCQ-195 |
CDK | Cell Cycle/Checkpoint |
NVP-LCQ195 (LCQ-195) 是CDK 杂环类抑制剂,对CDK1,CDK2,CDK3和CDK5的IC50为1到42 nM 之间。 | |||
T23093 | NSC 693868 | Others | Others |
CDKs and GSK-3 inhibitor | |||
T11345 |
Lerociclib
G1T38 |
CDK | Cell Cycle/Checkpoint |
Lerociclib (G1T38) is a potent and selective inhibitor of CDK4/6, with IC50s of 2nM, 1 nM for CDK6/CyclinD3 and CDK4/CyclinD1, respectively. |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-00873 |
Lipocalin-2/LCN2 Protein, Human, Recombinant (His)
MSFI,24p3,lipocalin 2,NGAL,Lipocalin-2,p25 |
Human | HEK293 Cells |
Lipocalin-2/LCN2 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 22.7 kDa and the accession number is P80188-1. | |||
TMPK-00085 |
NGAL/Lipocalin-2 Protein, Human, Recombinant (hFc)
NGAL,Lipocalin-2,Oncogene 24p3,MSFI,Siderocalin LCN2,p25... |
Human | HEK293 Cells |
NGAL/Lipocalin-2 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with C-hFc tag. The predicted molecular weight is 47.2 kDa and the accession number is P80188-1. | |||
TMPK-01289 |
NGAL/Lipocalin-2 Protein, Cynomolgus, Recombinant (His)
Siderocalin LCN2,Oncogene 24p3,Lipocalin-2,p25,MSFI... |
Cynomolgus | HEK293 Cells |
NGAL/Lipocalin-2 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 21.51 kDa and the accession number is XP_005580845.3. | |||
TMPY-00148 |
TMED9 Protein, Human, Recombinant (His)
p25,GP25L2,GMP25,HSGP25L... |
Human | HEK293 Cells |
TMED9 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 20.8 kDa and the accession number is A0A024R7M0. | |||
TMPY-00531 |
TMED9 Protein, Human, Recombinant (mFc)
GP25L2,HSGP25L2G,transmembrane p24 traffic... |
Human | HEK293 Cells |
TMED9 Protein, Human, Recombinant (mFc) is expressed in HEK293 mammalian cells with mFc tag. The predicted molecular weight is 45.8 kDa and the accession number is A0A024R7M0. | |||
TMPH-01088 |
CBX5 Protein, Human, Recombinant (His & Myc)
HP1 alpha,CBX5,Heterochromatin protein 1 homolog alpha,Chrom... |
Human | E. coli |
Component of heterochromatin that recognizes and binds histone H3 tails methylated at 'Lys-9' (H3K9me), leading to epigenetic repression. In contrast, it is excluded from chromatin when 'Tyr-41' of histone H3 is phosphorylated (H3Y41ph). Can interact with lamin-B receptor (LBR). This interaction can contribute to the association of the heterochromatin with the inner nuclear membrane. Involved in the formation of functional kinetochore through interaction with MIS12 complex proteins. CBX5 Protein... | |||
TMPJ-00082 |
NGAL/Lipocalin-2 Protein, Mouse, Recombinant (hFc)
Lipocalin-2,SV-40-induced 24P3 protein,Siderocalin LCN2,LCN2... |
Mouse | HEK293 Cells |
Lipocalin-2, also known as Neutrophil Gelatinase-Associated Lipocalin (NGAL), is a secretory protein of the lipocalin superfamily. Lipocalin-2 contains a signal peptide that enables it to be secreted and form complexes with matrix metalloproteinase-9 (MMP-9) through disulfide bonds. Similar to other lipocalin family members, Lipocalin-2 is involved in diverse cellular processes, including the transport of small hydrophobic molecules, protection of MMP-9 from proteolytic degradation, and cell sig... | |||
TMPH-00603 |
Cytidylate kinase Protein, E. coli, Recombinant (His & SUMO)
Cytidine monophosphate kinase,CMP kinase,ycaF,Cytidylate kin... |
E. coli | E. coli |
ATP, dATP, and GTP are equally effective as phosphate donors. CMP and dCMP are the best phosphate acceptors. | |||
TMPJ-01068 |
FKBP25/FKBP3 Protein, Human, Recombinant (His)
25 kDa FKBP,FKBP-3,Peptidyl-prolyl cis-trans isomerase FKBP3... |
Human | E. coli |
FKBP25 contains 1 PPIase FKBP-type domain, belongs to the FKBP-type PPIase family. FK506- and rapamycin-binding proteins (FKBPs) constitute a family of receptors for the two immunosuppressants which inhibit T-cell proliferation by arresting two distinct cytoplasmic signal transmission pathways. FKBP3 is a cis-trans prolyl isomerase enzyme that binds the immunosuppressants FK506 and rapamycin, as well as histone deacetylases, the transcription factor YY1, casein kinase II, and nucleolin. It has a... | |||
TMPY-02259 |
FKBP25/FKBP3 Protein, Human, Recombinant (GST)
FKBP-25,PPIase,FKBP25,FK506 binding protein 3,FKBP-... |
Human | E. coli |
FKBP3 is a member of FK506-binding proteins (FKBPs). miR-145-5p overexpression suppressed cell proliferation of NSCLC cells which was abrogated by FKBP3 overexpression, that FKBP3/Sp1/HDAC2/p27 control cell proliferation during NSCLC development. | |||
TMPH-02683 |
GSTP1 Protein, Mouse, Recombinant (His & SUMO)
|
Mouse | E. coli |
Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Involved in the formation of glutathione conjugates of both prostaglandin A2 (PGA2) and prostaglandin J2 (PGJ2). Participates in the formation of novel hepoxilin regioisomers. Regulates negatively CDK5 activity via p25/p35 translocation to prevent neurodegeneration. | |||
TMPH-01399 |
GSTP1 Protein, Human, Recombinant (His)
|
Human | P. pastoris (Yeast) |
Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Involved in the formation of glutathione conjugates of both prostaglandin A2 (PGA2) and prostaglandin J2 (PGJ2). Participates in the formation of novel hepoxilin regioisomers. Regulates negatively CDK5 activity via p25/p35 translocation to prevent neurodegeneration. GSTP1 Protein, Human, Recombinant (His) is expressed in yeast with N-6xHis tag. The predicted molecular weight is 25.2 kDa and... | |||
TMPH-01398 |
GSTP1 Protein, Human, Recombinant (E. coli, His)
|
Human | E. coli |
Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Involved in the formation of glutathione conjugates of both prostaglandin A2 (PGA2) and prostaglandin J2 (PGJ2). Participates in the formation of novel hepoxilin regioisomers. Regulates negatively CDK5 activity via p25/p35 translocation to prevent neurodegeneration. GSTP1 Protein, Human, Recombinant (E. coli, His) is expressed in E. coli expression system with N-10xHis tag. The predicted mo... | |||
TMPJ-00499 |
GSTP1 Protein, Human, Recombinant
GSTP1,GST3,GST class-pi,Glutathione S-transferase P,FAEES3,G... |
Human | E. coli |
Glutathione S-transferase P (GSTP1) is an enzyme that contains 1 GST C-terminal domain, 1 GST N-terminal domain. GSTP1 belongs to the GST superfamily, the GSTs are a family of enzymes that play an important role in detoxification by catalyzing the conjugation of many hydrophobic and electrophilic compounds with reduced glutathione. Based on their biochemical, immunologic, and structural properties, the soluble GSTs are categorized into 4 main classes: alpha, mu, pi, and theta. The glutathione ... |